Stereotaxis
    Print Page  Close Window
S-1/A
STEREOTAXIS, INC. filed this Form S-1/A on 06/17/2004
Entire Document
 << Previous Page | Next Page >>
Table of Contents

STEREOTAXIS, INC.

STATEMENTS OF STOCKHOLDERS’ EQUITY — (Continued)

                                                   
Convertible
Preferred Stock Common Stock Additional
Comprehensive

Paid-In
Income (Loss) Shares Amount Shares Amount Capital






Issuance of Series D-2 convertible preferred stock at $2.17 per share, net of issuance costs of $287,262
          7,940,951       7,941                   15,352,459  
Exercise of stock warrants
          205,791       206                   289,365  
Exercise of stock options
                      461,242       461       93,877  
Interest receivable from sale of stock
                                   
Deferred compensation
                                  98,474  
Stock-based compensation
                                   
Payments of notes receivable from sale of stock
                                   
Issuance of warrants to purchase common stock
                                  1,584,202  
Issuance of warrants to purchase convertible preferred stock in connection with long-term debt
                                  192,637  
Net loss
    (21,458,658 )                              
Other comprehensive income (loss):
                                               
 
Unrealized loss on short term investments
                                   
     
                                         
Comprehensive loss
    (21,458,658 )                              
     
     
     
     
     
     
 
Balance at December 31, 2002
            51,635,017       51,635       5,003,891       5,004       88,442,639  

[Additional columns below]

[Continued from above table, first column(s) repeated]

                                                   
Notes Accumulated
Receivable Other Total
Deferred Treasury From Sale Accumulated Comprehensive Stockholders’
Compensation Stock of Stock Deficit Income (Loss) Equity






Issuance of Series D-2 convertible preferred stock at $2.17 per share, net of issuance costs of $287,262
                                  15,360,400  
Exercise of stock warrants
                                  289,571  
Exercise of stock options
                                  94,338  
Interest receivable from sale of stock
                (28,758 )                 (28,758 )
Deferred compensation
    (98,474 )                              
Stock-based compensation
    483,638                               483,638  
Payments of notes receivable from sale of stock
                12,585                   12,585  
Issuance of warrants to purchase common stock
                                  1,584,202  
Issuance of warrants to purchase convertible preferred stock in connection with long-term debt
                                  192,637  
Net loss
                      (21,458,658 )           (21,458,658 )
Other comprehensive income (loss):
                                               
 
Unrealized loss on short term investments
                                   
Comprehensive loss
                                   
     
     
     
     
     
     
 
Balance at December 31, 2002
    (674,344 )     (15 )     (439,345 )     (63,378,928 )           24,006,646  

See accompanying notes.

F-6


 << Previous Page | Next Page >>